Engineered Regeneration (ER)

Engineered Regeneration (ENGREG) is an interdisciplinary, peer-reviewed journal focused on research in tissue engineering, regenerative medicine and human disease treatment. The journal invites submissions covering all aspects of tissue and organ development, regeneration, repair and modelling. The journal serves as a bridge connecting engineering, biotechnology, life sciences, pharmaceutics and medicine, with the goal of advancing disease modelling, treatment strategies and human health. By providing a dedicated forum for novel scientific findings, technological developments and practical applications, ENGREG aims to foster research that ultimately improves human health. ENGREG welcomes research that merges various scientific and engineering disciplines to deepen our understanding and improve treatment effectiveness. The journal publishes original research articles, review, and perspective papers addressing key topics in disease management and treatment, tissue regeneration, and repair.

Engineered Regeneration (ER) is :-

• International, Peer-Reviewed, Open Access, Refereed, Tissue engineering, Regenerative medicine, Biomaterials and bioengineering, Stem cell research, 3D bioprinting and scaffolds, Biomedical engineering applications, stem cell biology, biomaterials development, scaffold fabrication, bioactive molecules, advanced manufacturing techniques such as 3D bioprinting, particularly in orthopedics, cardiovascular medicine, neural regeneration , Online , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2666-1381, Established: 2020,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE